| Title |
An update on the safety and efficacy of decitabine in the treatment of myelodysplastic syndromes
|
|---|---|
| Published in |
OncoTargets and therapy, February 2010
|
| DOI | 10.2147/ott.s7222 |
| Pubmed ID | |
| Authors |
Jacqueline S Garcia, Nitin Jain, Lucy A Godley |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 22 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 1 | 5% |
| Researcher | 1 | 5% |
| Student > Master | 1 | 5% |
| Unknown | 19 | 86% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 2 | 9% |
| Unknown | 20 | 91% |
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 February 2014.
All research outputs
#8,882,501
of 26,017,215 outputs
Outputs from OncoTargets and therapy
#587
of 3,040 outputs
Outputs of similar age
#53,065
of 177,406 outputs
Outputs of similar age from OncoTargets and therapy
#2
of 4 outputs
Altmetric has tracked 26,017,215 research outputs across all sources so far. This one is in the 42nd percentile – i.e., 42% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,040 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done well, scoring higher than 75% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,406 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.